NCT04919473

A Phase I/IIa Open Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa

Study Summary

The purpose of the study is to evaluate the safety and tolerability of a single intravitreal injection of virally-carried Multi-Characteristic Opsin I (vMCO-I)

Want to learn more about this trial?

Request More Info

Interventions

Gene Therapy product:vMCO-IBIOLOGICAL
The vMCO-I is an adeno-associated virus serotype 2-based vector carried multi-characteristic opsin (MCO) gene expression cassette

Study Locations

FacilityCityStateCountry
JPM Rotary Club of Cuttack Eye Hospital and Research InstituteCuttackOdishaIndia

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026